FMS FY 2008 Earnings Report — Fresenius Medical Care AG & Co. KGaA Revenue & Financial Results | Market Cap Arena

Fresenius Medical Care AG & Co. KGaAFMS

FY 2008 Earnings

Reported February 20, 2009

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2008	Prior Q	FY 2007	QoQ Change	YoY Change
Revenue	$8.9B	—	$7.8B	—	14.3%
Op. Income	$1.4B	—	$1.3B	—	10.9%
Gross Margin	34.2%	—	34.5%	—	-0.3pp
Net Margin	7.7%	—	7.4%	—	0.3pp
EPS (Diluted)	$1.15	—	$0.97	—	18.1%
Free Cash Flow	$276M	—	$497M	—	-44.4%

Revenue Flow

Item	Amount
REVENUE	$8.9B
Cost of Revenue	$5.9B
GROSS PROFIT	$3.0B
R&D Expenses	$67M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$1.6B
Other Expenses	$0
Operating Expenses	$1.6B
Cost & Expenses	$7.5B
OPERATING INCOME	$1.4B
Interest Income	$21M
Interest Expense	$304M
Other Income/Expenses	-$283M
INCOME BEFORE TAX	$1.1B
Income Tax Expense	$411M
Net Income from Continuing Ops	$722M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$687M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$687M
D&A	$349M
EBIT	$1.4B
EBITDA	$1.8B
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$8.9B
Cost of Revenue	$5.9B
GROSS PROFIT	$3.0B
R&D Expenses	$67M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$1.6B
Other Expenses	$0
Operating Expenses	$1.6B
Cost & Expenses	$7.5B
OPERATING INCOME	$1.4B
Interest Income	$21M
Interest Expense	$304M
Other Income/Expenses	-$283M
INCOME BEFORE TAX	$1.1B
Income Tax Expense	$411M
Net Income from Continuing Ops	$722M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$687M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$687M
D&A	$349M
EBIT	$1.4B
EBITDA	$1.8B
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$687M
Depreciation & Amortization	$349M
Stock-Based Compensation	$27M
Deferred Income Tax	-$18M
Other Non-Cash Items	$162M
Change in Working Capital	-$353M
OPERATING CASH FLOW	$854M
Capital Expenditure	-$577M
Acquisitions (Net)	-$183M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$12M
NET CASH FROM INVESTING	-$749M
Net Debt Issuance	$265M
Common Stock Repurchased	-$570M
Common Dividends Paid	-$212M
Other Financing Activities	$386M
NET CASH FROM FINANCING	-$131M
FREE CASH FLOW	$276M
Net Change in Cash	-$19M

Balance Sheet

Item	Amount
Cash & Equivalents	$186M
Short-Term Investments	$0
Net Receivables	$2.0B
Inventory	$594M
Other Current Assets	$272M
TOTAL CURRENT ASSETS	$3.5B
PP&E (Net)	$1.9B
Goodwill	$6.1B
Intangible Assets	$711M
Long-Term Investments	$0
Tax Assets	$78M
Other Non-Current Assets	$187M
TOTAL NON-CURRENT ASSETS	$9.0B
TOTAL ASSETS	$12.5B
Account Payables	$307M
Short-Term Debt	$957M
Deferred Revenue	$0
Other Current Liabilities	$24M
TOTAL CURRENT LIABILITIES	$2.6B
Long-Term Debt	$3.3B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$358M
Other Non-Current Liabilities	$1.1B
TOTAL NON-CURRENT LIABILITIES	$4.7B
TOTAL LIABILITIES	$7.4B
Common Stock	$0
Additional Paid-In Capital	$3.1B
Retained Earnings	$2.1B
Treasury Stock	$0
Accum. Other Comp. Income	-$127M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$5.0B
Minority Interest	$0
TOTAL EQUITY	$5.1B
TOTAL LIABILITIES & EQUITY	$12.5B
Total Debt	$4.3B
Net Debt	$4.1B